<DOC>
	<DOC>NCT00921752</DOC>
	<brief_summary>To demonstrate a higher percent rate of achieved target lipid goals among patients at high cardiovascular risk using more potent lipid-lowering treatment options including high-potency statins and combination therapies.</brief_summary>
	<brief_title>C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS)</brief_title>
	<detailed_description />
	<criteria>Patients at high cardiovascular risk according to Framingham or SCORE rates Not eligible for lipid or statin therapy Intolerance to therapy Patients at low or intermediate CV risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Lipid therapy</keyword>
	<keyword>high CV risk</keyword>
	<keyword>lipid goal attainment</keyword>
	<keyword>High cardiovascular risk patients</keyword>
</DOC>